Last reviewed · How we verify

NCT03873155

The Effectiveness of Mindfulness Based Cognitive Group Therapy for Social Anxiety Symptoms in People Living With Alopecia Areata

Completed NA Last updated 1 October 2019
What this trial tests

NA trial testing Mindfulness Based Cognitive Therapy in Alopecia Areata in 6 participants. Completed in 23 September 2019.

Timeline
14 March 2019
Primary endpoint
20 August 2019
23 September 2019

Quick facts

Lead sponsorUniversity of Sheffield
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment6
Start date14 March 2019
Primary completion20 August 2019
Estimated completion23 September 2019
Sites2 locations across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Sheffield

Who can join

Adults 16 to 99, any sex, with Alopecia Areata or Social Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigates the impact of mindfulness based cognitive therapy (MBCT) on social anxiety in adults with alopecia areata. A single-group case-series design will be adopted.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Mindfulness Based Cognitive Therapy

Trials testing the same drug.

Other recruiting trials for Alopecia Areata

Currently open trials in the same condition.

Other University of Sheffield trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03873155.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing